Industry News
Pharmaceutical Industry News
New report joins calls from Roche, AstraZeneca to boost cancer screening as rates still down 2 years into pandemic
New report joins calls from Roche, AstraZeneca to boost cancer screening as rates still down 2 years into pandemic nmissakian Wed, 01/26/2022 - 13:10
What to Do if You’ve Lost Your Covid-19 Vaccination Card
It never quite fit in your wallet, so it’s no surprise you may have misplaced it by now.
Court ruling on bluebird bio’s gene therapy marketing campaign ‘sparks’ dismay at Roche’s Spark
Court ruling on bluebird bio’s gene therapy marketing campaign 'sparks' dismay at Roche's Spark aliu Wed, 01/26/2022 - 11:12
BioNTech preps hiring spree at mRNA vaccine plant, boosting workforce by 50%
BioNTech preps hiring spree at mRNA vaccine plant, boosting workforce by 50% fkansteiner Wed, 01/26/2022 - 11:04
Immunocore wins FDA nod for first uveal melanoma treatment, also first T-cell receptor therapeutic
Immunocore wins FDA nod for first uveal melanoma treatment, also first T-cell receptor therapeutic kdunleavy Wed, 01/26/2022 - 10:21
AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger
AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger fkansteiner Wed, 01/26/2022 - 09:29
FDA chides Eli Lilly for second misleading ad in 2 months, this time for diabetes blockbuster Trulicity
FDA chides Eli Lilly for second misleading ad in 2 months, this time for diabetes blockbuster Trulicity fkansteiner Tue, 01/25/2022 - 12:55
FDA chides Eli Lilly for 2nd misleading ad in 2 months, this time for diabetes blockbuster Trulicity
FDA chides Eli Lilly for 2nd misleading ad in 2 months, this time for diabetes blockbuster Trulicity fkansteiner Tue, 01/25/2022 - 12:55
Johnson & Johnson CEO: Consumer health split won’t interfere with our ‘more aggressive’ approach to M&A
Johnson & Johnson CEO: Consumer health split won't interfere with our 'more aggressive' approach to M&A kdunleavy Tue, 01/25/2022 - 11:34
Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the door open for off-label use
Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the door open for off-label use aliu Tue, 01/25/2022 - 11:19
Samsung Biologics outlines mRNA ambitions as “Super Plant” speeds toward completion
Samsung Biologics outlines mRNA ambitions as "Super Plant" speeds toward completion fkansteiner Tue, 01/25/2022 - 10:56
EpiPen rival raises $39M to fund smaller, longer-lasting product
EpiPen rival raises $39M to fund smaller, longer-lasting product ntaylor Tue, 01/25/2022 - 09:11
Roche’s aim to widen Evrysdi’s label nabs speedy FDA review in young spinal muscular atrophy patients
Roche's aim to widen Evrysdi's label nabs speedy FDA review in young spinal muscular atrophy patients fkansteiner Tue, 01/25/2022 - 09:11
WuXi STA opens new sterile manufacturing line at Wuxi City site
WuXi STA opens new sterile manufacturing line at Wuxi City site jkeenan Tue, 01/25/2022 - 08:31
Pfizer goes subtle on vaccine but big on human spirit in latest ad spot
Pfizer goes subtle on vaccine but big on human spirit in latest ad spot sharon.coey Tue, 01/25/2022 - 08:07
Topical combo based on Pfizer and Novartis drugs advances after clearing early clinical test
Topical combo based on Pfizer and Novartis drugs advances after clearing early clinical test ntaylor Tue, 01/25/2022 - 06:46
Novaliq eyes dermatology opportunity, spinning off 3 programs and securing $15M for clinical trials
Novaliq eyes dermatology opportunity, spinning off 3 programs and securing $15M for clinical trials ntaylor Tue, 01/25/2022 - 06:42
J&J extends long-acting injectable biologic pact after Midatech clears early milestone
J&J extends long-acting injectable biologic pact after Midatech clears early milestone ntaylor Tue, 01/25/2022 - 06:39
Bayer leads $80M funding round for Cellino, betting on new cell therapy manufacturing platform
Bayer leads $80M funding round for Cellino, betting on new cell therapy manufacturing platform kdunleavy Tue, 01/25/2022 - 00:48
FDA bans Lilly, Regeneron antibody use in COVID-19 patients infected by omicron
FDA bans Lilly, Regeneron antibody use in COVID-19 patients infected by omicron kdunleavy Mon, 01/24/2022 - 17:26